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ABSTRACT 
 Placebo and nocebo effects have been a widely concerning issue, as they describe the 
psychological factors influencing medication outcomes. Previous research mostly focused on 
how placebo and nocebo effects occur, offering explanations for their mechanisms. Individual 
differences, especially at the cultural level, are seldom discussed in relation to 
placebo/nocebo effects. In this paper I consider how cultural backgrounds might influence 
placebo and nocebo effects elicited by people’s processing of pharmaceutical advertisements. 
I proposed that cultural differences in people’s dialectical thinking propensity would 
influence their processing of conflicting information about drug effects contained in the ads. 
And I proposed that differential information processing would cause differences in people’s 
expectancies about the drugs’ effects. The hypotheses were not supported in the results. 
Possible reasons were discussed. 
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CHAPTER 1: INTRODUCTION 
A placebo effect is a psychological or physiological effect resulting from patients’ 
interpretation and expectations of a substance or procedure, but is not due to the inherent 
therapeutic power of the drug itself (Stewart-Williams & Podd, 2004; Moerman, 2002; Price, 
Finniss & Benedetti, 2008; Shapiro & Morris, 1978). Placebo effects have been a concern for 
a long time, not only as an inert treatment that is administered under controlled conditions to 
test the true effect of medicine (Geers & Rose, 2011), but also as a component of almost 
every medical treatment. It refers to the proportion of the effectiveness caused not by the 
active ingredient in the medicine, but by psychological power that causes a 
psychophysiological reaction. Placebo effects are not exclusively beneficial; placebos can 
also cause unintended side effects. This adverse experience induced by placebos is known as 
a nocebo effect (Barsky, Saintfort, Rogers & Borus, 2002).  
As placebo/nocebo effects could influence medical treatments, studies have been done to 
understand the mechanism underlying these effects (e.g., Montgomery & Kirsch, 1997), as 
well as variation in the strength of these effects (Geers & Rose, 2011). Most research on 
placebo/nocebo effects uses expectancies as the key mechanism by which effects occur 
(Montgomery & Kirsch, 1997). An individual’s expectancy could influence her psychological 
conditions then induce a psychophysiological reaction; or an expectancy could lead to 
specific psychological interpretive framing that shifts a neutral experience in the direction of 
her expectancy (Geers & Rose, 2011).  
Many contextual factors can influence placebo/nocebo effects. For example, the 
information provided about a particular drug could play a major role in the occurrence of 
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placebo/nocebo effects, as people form their expectancy about a drug’s performance based on 
the information they get about the drug (e.g., Benedetti, 2008). This information could be 
seen in ads, verbal as well as written instructions, and in consent forms before medical 
treatments. An individual’s previous experience could also influence placebo/nocebo effects, 
as they might expect the previously experienced physical feelings to occur again if they take 
a similar or the same drug after a few times (Benedetti, Pollo, Lopiano, Lanotte, Vightti, et 
al., 2003). Placebo as well as nocebo effects are also believed to be greatly influenced by 
individual differences. For example, individuals differ in their psychological susceptibility to 
placebo effects (Horne, Faasse, Cooper, Diefenbach, Leventhal, Leventhal, & Petrie, 2013). 
However, as a source of collective difference, cultures are seldom studied regarding this 
issue.  
There are many studies showing that Eastern people tend to think holistically, which 
means that they tend to think of objects and the environment as a whole; Western people tend 
to think analytically, they tend to decontextualize objects from their original background 
(Nisbett, Peng, Choi & Norenzayan, 2001). Dialectical thinking propensity, which refers to 
people’s tendency to attend to change, contradiction, and multiple perspectives when 
processing information is a related cultural distinction in thinking style (Nisbett et al. 2001). 
This could possibly affect how people might differ in their processing of double-sided 
information (both positive and negative effect information) about drugs. However, little has 
been done examining this cultural difference in the realm of placebo/nocebo effects. A 
knowledge gap exists regarding how distinctions in people’s dialectical thinking propensity 
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might lead to diverse drug information comprehension, and differential expectancy 
generation. One prominent way drug information is delivered is via advertising. 
As a sort of verbal suggestion delivered through mass media, we can view 
pharmaceutical advertising as a contextual factor affecting placebo and nocebo effects. 
Pharmaceutical ads have been a concern in the health communication industry because 
people may misinterpret ad messages and either underestimate or overestimate side effects 
conveyed (Avery, Eisenberg & Simon, 2012; Cox, Cox & Mantel, 2010; Maat & Klaassen, 
1994). Also, the way pharmaceutical ads convey risk information can influence how people 
comprehend the information and may lead them to expect different outcomes (e.g., Cox et al., 
2010; Matt & Klaassen, 1994). Pharmaceutical ads could also be used to observe cultural 
influences on how people process drug information, as advertising is a common way to 
deliver drug information in many cultures. We can use pharmaceutical ads to explore how 
drug information presented in an ad might change placebo/nocebo effects, and how 
individuals from different cultures might react differently towards the ads. These possible 
influences have not been systematically studied. 
In this thesis I will explore whether placebo/nocebo effects elicited by pharmaceutical 
ads differ depending on viewers’ cultural backgrounds, and if so, whether this difference 
could be influenced by different features of the pharmaceutical ads. In this research, 
participants from both Eastern (China) and Western (U.S.) cultures were exposed to 
pharmaceutical ads that vary in their specificity and were then asked about the likelihood they 
would experience the effects mentioned in the ads. The findings from this study can hopefully 
contribute to research on cultural differences, placebo effects and pharmaceutical advertising. 
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If there really are differences buried in culturally-based cognitive processes that determine 
different responses to risk information within pharmaceutical ads, we can illuminate how to 
communicate with patients more effectively, in ways that correspond to different types of 
cognitive processing. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Placebo and Nocebo Effects 
Medical procedures are always accompanied by psychological factors influencing the 
therapeutic outcomes (Benedetti, 2002; Price, Finniss, & Benedetti, 2008; Di Blasi et al., 
2001; Geers & Rose, 2011). What patients experience may not only come from the objective 
effect caused by the active ingredient in the medication, but also how they subjectively 
perceive their experience. This subjective, psychological influence could be affected by 
contextual factors like verbal suggestions from doctors (Thomas, 1987), behaviors of 
healthcare providers (Price et al. 2008), or the doctor-patient relationship (Stewart, 
McWhinney & Buck, 1979). This psychological influence on the therapeutic outcomes, also 
named placebo effect, has been a concern in medical practice, as well as in research. 
(Moerman, 2002).  
Placebo effects were first intentionally applied to clinical treatments to create concurrent 
controlled conditions, in order to separate what was caused by the active content of the 
medicine from the whole effect elicited by the treatment, including a specific medication 
(Diehl et al., 1938). However, placebo effects are not limited to responses to placebo used as 
a control in clinical trials (Shapiro, 1964); placebo effects are at least partially responsible for 
beneficial or detrimental outcomes in every medical treatment (Geers & Rose, 2011; 
Harrington, 1997). The detrimental part of the effects, referred to as nocebo effects, describes 
the “noxious or distressing effects of a placebo” (Barsky et al., 2002, p. 662. Nocebo effects, 
like placebo effects, include not only the effects elicited by placebo used in clinical trials, but 
also those negative feelings contained within the everyday medical treatment. 
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When studying how placebo effects occur, researchers usually look at patients’ 
expectancies regarding symptom relief preceding the administration of a placebo, as is 
demonstrated in both Western and Eastern cultres (e.g., Montgomery & Kirsch, 1997; Price, 
Milling, Kirsch, Duff, & Montgomery, 1999; Zhang & Luo, 2009). Expectations affect 
placebo effects as well as their magnitude in several possibly overlapping ways. For example, 
an expectation of beneficial results from a medical treatment can increase pleasant feelings 
and trigger biological reward mechanisms in people’s brains (Benedetti, 2008), increasing the 
level of dopamine (Scott, Stohler, Egnatuk, Wang, Koeppe, & Zubieta, 2008), inducing 
positive physical feelings. Expectations for symptom relief can also suppress or reduce 
negative feelings, such as anxiety, through increasing the level of opioid (Petrovic, Dietrich, 
Fransson, Andersson, & Carlsson, 2005; Scott et al., 2008). In addition, expectations can act 
as a frame to guide one’s interpretation of their feelings, thus redirecting a patient’s attention, 
detection, appraisal, and recall of symptoms to be consistent with their expectancies (Geers, 
Weiland, Kosbab, Landry, & Helfer, 2005; Geers & Rose, 2011).  
Like placebo effects, it is widely believed that nocebo effects are also caused by people’s 
expectations (Faasse & Petrie, 2013; Well & Kaptchuk, 2012). Also, nocebo effects are based 
on the same biological foundation of dopamine and opioid activity as placebo effects, with 
the levels of dopamine and opioid increasing in placebo effects and decreasing in nocebo 
effects (Scott et al., 2008). Empirical studies have demonstrated that as the experience of 
positive effects rise, the experience of side effects may decrease, and vice versa (Bartley, 
Faasse, Horne, & Petrie, 2016), supporting the idea that placebo and nocebo effects share the 
same mechanism, but in opposite directions.  
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What causes people to form expectancies that induce placebo/nocebo effects? Verbal 
suggestions from doctors (Gönül, Carter, Petrova, & Srinivasan, 2001), drug instructions and 
consent forms (Wells & Kaptchuk, 2012) could all influence what patients expect their 
medical outcomes to be. However, pharmaceutical advertisements, as an important form of 
drug information, are seldom studied regarding their possible influences on people’s 
expectancies preceding placebo/nocebo effects. Several factors in pharmaceutical ads could 
influence people’ perception of the risk and benefit probability, including the amount of 
information (Mazis, McNeil & Bemhardt, 1985), and the specificity and format of 
information delivery. An increase in the specificity of risk information can increase 
consumers’ elaboration on the information, thus cause greater awareness towards the risk 
(Morris, Mazis & Brinberg, 1989). As well, people’s perception of the positive attributes can 
be harmed by the warning information contained in the ads (Morris et al., 1989; Maat & 
Klaassen, 1994). Thus, pharmaceutical ads, as well as their format, could influence how 
people form expectancies of the drugs’ positive and negative effects, which would later affect 
placebo/nocebo effects. 
In this paper, I will use dietary supplement ads to test placebo/nocebo effects, as they’re 
both legal and common in most of the world (World Self-Medication Industry, 2008). Risk 
information specificity (as is frequently used in both ad practice and research) will be 
manipulated to influence people’s expectations for both the positive and side effects.  
Although pharmaceutical advertisements might have an impact on people’s expectancies, 
the evidence for this idea comes from studies mostly done in the U.S. Research has also been 
done in Eastern cultures demonstrating the existence of placebo/nocebo effects (Liu, Cui & 
8 
 
Meng, 2003), however, pharmaceutical ad’s influence on this effect is seldom discussed in an 
Eastern context. People from different cultures are known to differ in their information 
processing styles (Nisbett et al., 2001). It is possible that when dealing with pharmaceutical 
ads, people form expectancies for the medicines’ effects differently because of different 
information processing styles. However, this issue has not yet been studied. In the next 
section, I will look at the issue of people’s expectancies about drugs’ effects through a lens of 
cultural differences.  
2.2 Comparing Cultural Differences 
Holistic vs. Analytic Thinking Styles. Cultures are believed to be closely related to 
many aspects of life, for example how people think and behave (e.g., Peng & Nisbett, 1999). 
Differences between Eastern and Western people’s cognitive processing styles are likely 
derived from ancient social practices (Larrick, Nisbett, & Morgan, 1993; Nisbett, Fong, 
Lehman, & Cheng, 1987; Smith, Langston, & Nisbett, 1992). Ancient China’s civilization 
valued obligation and the surrender of freedom to the larger social organism, whereas ancient 
Greek civilization was characterized by personal freedom and an absence of social constraint. 
These early differences cultivated different psychological attributes and shaped people’s 
metaphysical beliefs in Eastern versus Western cultures (Lloyd, 1990; Nisbett et al., 2001). 
Extended from social practices focusing on in-group harmony, Eastern belief is therefore 
oriented towards the context or field as a whole, while the Western social practice, which 
treasures individual freedom, emphasizes decontextualizing objects from their original 
background. This has led to different epistemologies—ways to observe and understand the 
world.  
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Eastern people see the relationship between focal objects and the environment as 
important in their social observation and practice, while Western people focus more on the 
attributes and use explicit evaluative guidelines when describing an object (Nisbett et al., 
2001). These differences in people’s metaphysical beliefs and epistemologies cause them to 
go through different styles of cognitive processing when confronted with information. People 
in Eastern cultures tend to be more holistic, while people in Western cultures tend to be more 
analytic (Peng & Nisbett, 1999).  
Holistic processing is more dialectical, which means that there is a tendency to attend to 
change, contradiction, and multiple perspectives when processing information. Also, there is 
an inclination to search for a “middle way” when dealing with opposing propositions, and 
find solutions that are somewhat reasonable (but might not be absolutely right) to both sides 
at the same time (Nisbett et al., 2001). Being analytic, on the other hand, refers to a 
preference for viewing the world as “a collection of discrete objects” (Nisbett et al., 2001, p. 
293) that can be categorized, explained, and predicted using explicit guidelines (Peng & 
Nisbett, 1999; Nisbett et al. 2001). Analytic thinkers tend to decontextualize structure from 
the content and follow formal logic to make inferences about objects or issues, at the same 
time reducing contradiction to form a more one-sided opinion when making decisions 
(Witkin, Dyk, Faterson, Goodenough, & Karp, 1974; Witkin, Lewis, Hertzman, Machover, 
Meissner, & Wapner , 1954). For example, when presented with a mother-daughter conflict 
that happens in people’s daily life, Chinese participants preferred dialectical resolutions that 
address the issue from both sides, while American people preferred nondialectical resolutions 
which attribute the fault to only one side (Nisbett & Peng, 1999). 
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This distinction in people’s propensity for dialectical thinking becomes more salient in 
circumstances where people are faced with simultaneously opposing information; dialectical 
thinking is largely responsible for cultural differences in processing opposing information. In 
Eastern cultures, as people’s attention is more likely to be concerned with the large picture, 
complexity, change, and contradiction in the environment are more salient. Therefore, it is not 
incompatible to simultaneously process opposite information in the same context (as a second 
step of paying attention to them), and hold the point of view that both A and not-A have merit 
(Lloyd, 1990), which is a reflection of people’s propensity to think dialectically. This results 
in a higher tolerance of information from opposite sides (Peng & Nisbett, 1999). On the other 
hand, Western people’s tendency towards logical rules guides attention directly towards 
categorizing items into structures and systems, resulting in seeing objects as organized 
elements without opposing relations between each other. Therefore, Western analytic thinking 
causes avoidance of a situation where both A and not-A are reasonable, but rather encourages 
a decision of whether A, or not-A, is the case (Peng & Nisbett, 1999). This strategy towards 
opposite information can be seen as a reflection of their lower propensity of dialectical 
thinking, and results in a lower tolerance for contradictory information and a stronger 
tendency to reduce contradictory information, which leads to the formation of more one-sided 
opinions. This is generally how the cultural difference in people’s preference for dialectical 
thinking (Eastern) vs. contradiction avoidance (Western) influences their tolerance for 
conflicting information (Nisbett et al. 2001; Nordgren, Harreveld, & Pligt, 2006; Spencer-
Rodgers Williams, & Peng, 2010). In the next section, I discuss how the feeling of 
ambivalence could influence people’s information processing and judgment formation, and 
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how ambivalence tolerance influences how people deal with their ambivalent attitudes in 
forming judgments. 
Ambivalence Tolerance and Processing Conflicting Information. The phenomenon of 
ambivalence describes the “co-existence of positive and negative dispositions towards an 
attitude object” (Nordgren et al., 2006, p.254). Cultural orientation affects people’s tolerance 
for ambivalence, which refers to a cognitive tendency to accept contradictions or ambivalent 
beliefs (Peng & Nisbett, 1999; Peng, Spencer-Rodgers & Nian, 2006). People in Eastern, 
holistic cultures are more likely to have a higher tolerance for ambivalence in tasks involving 
the reconciliation of conflicting information, and they also tend to accept contradictory 
beliefs more readily than Western people (Choi & Choi, 2002; Spencer-Rodgers, Boucher, 
Mori, Wang, & Peng, 2009; Spencer-Rodgers et al., 2010). On the other hand, people in 
Western analytic cultures have lower tolerance for ambivalence and hold a stronger 
motivation to reduce incongruity. The whole process of ambivalence reduction described 
below is more apparent among Western people (Ng, Hynie & MacDonald, 2012).  
For those people who have relatively low tolerance for ambivalence, processing 
inconsistent information can cause cognitive dissonance (Festinger, 1957; Williams & Aaker, 
2002) and aversive feelings (Aaker, Drolet & Griffin, 2008; Nordgren et al., 2006), which 
leads to efforts to eliminate it by resolving the inconsistency (Festinger, 1957). When the 
uncomfortable feeling induced by conflicting information is low, people tend to use heuristic 
cues to make judgments, for example, their previous attitudes (Nordgren et al., 2006) and 
intrinsic beliefs (Nisbett et al., 1987). When the discomfort caused by the discrepancy 
increases to a level that motivates them to seriously consider conflicting information, people 
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tend to process the information in the situation more systematically and rely more on 
relatively persuasive cues (Morris & Peng, 1994; Aaker & Sengupta, 2000). As a result, they 
will tend to form unipolar thoughts and attitudes directed at the more persuasive side 
(Nordgren et al., 2006; Aaker et al., 2008).  
As described above, the different cognitive processing styles between Eastern holistic 
thinkers and Western analytic thinkers could lead to psychological or behavioral 
consequences, including cognition, comprehension, and behavioral outcomes (e.g., Okazaki 
& Kallivayalil, 2002; Okazaki, 2002). Perceptions of advertising, too, are influenced by 
culturally different information processing styles. Pharmaceutical advertisements contain 
both positive and side effect details: contradictory information. When reading pharmaceutical 
ads, Eastern and Western people’s different tolerance for ambivalence might trigger different 
thoughts about the ad information, eliciting different expectancies and attitudes. 
2.3 Current Study 
In this paper, I studied people from China and the U.S., representing Eastern and Western 
cultures where people differ in cognitive processing styles, to test how culture influences 
people’s perceptions of the effectiveness as well as risk information of an advertised 
supplement. I also studied the influence of risk information specificity on how people 
perceive as well as expect the benefits and risks associated with taking a supplement.  
The risk information was shown in either general terms or specific terms, as a 
manipulation of its specificity. More specific risk information in pharmaceutical ads leads to 
more elaboration and higher awareness of the risks (Morris et al., 1989). Also, specificity 
influences argument quality. More specific information was perceived to be more persuasive 
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and induced more attitude change (Leventhal, Singer & Jones, 1965). Therefore, the risk 
information specificity should have an impact on persuasiveness of the risk information, with 
more specific risk information being more persuasive.  
As the supplement’s benefits were described in detail in both conditions, the 
manipulation of risk information specificity should also affect the relative persuasiveness of 
side effect information and benefit information. For the general side effect information 
condition, benefits were described more specifically than side effects, so that benefits should 
be more persuasive than side effects and people would form higher expectancies for benefits 
than side effects. In the specific side effect information condition, the benefits and side effects 
were described in similar specificity, thus the benefit and side effect information should be 
similarly persuasive. However, as bad information tends to produce larger effects than good 
information (Baumeister, Bratslavsky, Finkenauer & Vohs, 2001), there should be more 
expectancies of side effects than benefits. Therefore, I am predicting an expectancy type 
(benefits v. side effects) by side effect specificity (general v. specific) interaction effect: 
H1: When risks are described in general terms, people’s expectancies towards the 
supplement’s benefits should be higher than their expectancies for side effects; When risks 
are described in specific terms, people’s expectancies for side effects should be higher than 
their expectancies for benefits (see Figure 1 for hypothesized results). 
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Figure 1 
Different expectancies of the supplement benefits and side effects should also be 
influenced by the interaction between cultural backgrounds and the specificity of side effect 
information. Western people have a lower tolerance for ambivalence than Eastern people, and 
should have stronger feelings of inconsistency when faced with conflicting information. 
Thus, Westerners should have a stronger tendency to reduce the inconsistency by deciding 
that the supplement is either beneficial, or harmful (via side effects). Eastern people, on the 
other hand, have higher tolerance for ambivalence. They should not have strong aversive 
feelings caused by inconsistency, and thus have little need to reduce the inconsistency by 
choosing a single side to take. When confronted with contradictory information, they should 
consider information from both sides, generate double-sided opinions and expect both 
benefits and side effects to occur. And information specificity should moderate these effects. 
First, I consider participants’ expectancies about benefits. I predict an interaction 
between cultural backgrounds and the specificity of side effect information on people’s 
expectancies of the supplement’s benefits. When side effects are described in general terms, 
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Western participants should find benefit information more convincing. This should cause 
them to form high expectancy for benefits. Eastern participants should consider information 
from both sides. And as Eastern participants should have little need to decide on just one 
single side to take, both positive and negative expectancies would be formed separately. 
Therefore, people from Eastern and Western cultures should process information about the 
supplement’s efficacy similarly, and both form high expectancies for benefits. 
When the side effect information becomes more specific and convincing, the benefit and 
side effect information should be similarly persuasive. However, when deciding a single side 
to take, Western people would be more sensitive to the negative side, because bad 
information tends to be more impactful than good information (Baumeister et al., 2001). 
Therefore, Western people should tend to take the negative side and have lower expectancies 
for benefits to occur, compared to when the side effects are described in general terms. 
Because Eastern people are more tolerant of contradictory information, an increase in side 
effect information specificity should not affect their expectancy of a supplement’s benefits. 
Thus, their expectancies for the supplement’s benefits should remain at the same level as 
when the side effects are described generally. For expectations about a supplement’s benefits, 
a cultural difference should emerge in Western and Eastern people’s expectancies only when 
side-effect information is specific (and therefore more persuasive), as Western people expect 
less positive effects than Eastern people. I am predicting an interaction between cultural 
backgrounds (Eastern v. Western) and side effect specificity (general v. specific) on people’s 
expectancies of the supplement’s benefits: 
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H2: When seeing pharmaceutical ads where side effects are described in general terms, 
Eastern people and Western people would expect similar levels of benefit. When seeing 
pharmaceutical ads where side effects are described in specific terms, Eastern people would 
expect more benefits to occur, compared to Western people (see Figure 2 for hypothesized 
results).  
 
Figure 2 
Next, I consider participants’ expectancies about side effects. I predict an interaction 
between culture and side effect specificity on people’s expectancies for the supplement’s side 
effects. When side effects are described in general terms, Western participants should find 
side effect information less convincing, causing them to have a lower expectancy for side 
effects. On the other hand, though the side effect information is not specific, Eastern people 
should still consider risk information and form expectancies of the possible side effects.   
When the side effect information becomes more specific and convincing, the benefit and 
side effect information should be similarly persuasive. Therefore, Western people should have 
higher expectancies for negative effects to occur (again, because negative information is more 
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impactful than positive information; Baumeister et al., 2001), compared to when the risks are 
described in general terms. Eastern people, on the other hand, should also perceive risk 
information to be more persuasive compared to when it is described in general, so that they 
would expect a greater likelihood of side effects. People from Eastern and Western cultures 
should not differ in their expectancies for side effects to occur, as they should process 
information about the supplement’s side effects similarly. For negative expectations about a 
supplement’s side effects, a cultural difference should emerge in Western and Eastern 
people’s expectancies only when side effect information is general (and therefore less 
persuasive), as Western people expect lower likelihood of side effects than Eastern people. I 
am predicting an interaction between cultural backgrounds (Eastern v. Western) and side 
effect specificity (general v. specific) on people’s expectancies of the supplement’s side 
effects: 
H3: When seeing pharmaceutical ads where side effects are described in general terms, 
Eastern people would expect more negative effects to occur, compared to Western people. 
When seeing pharmaceutical ads where side effects are described in specific terms, Eastern 
people and Western people would expect similar occurrence of side effects (see Figure 3 for 
hypothesized results). 
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Figure 3 
Taken together, hypotheses 2 and 3 represent a predicted three-way interaction among 
two between-participants variables (culture and side effect information specificity) and one 
within-participants variable (expectancies about benefits and side effects).  
H4: The interaction between culture and side effect specificity will differ for expectations 
about benefits and side effects. H2 describes the predicted interaction for expected benefits, 
and H3 describes the predicted interaction for expected side effects. 
I am proposing an asymmetry for positive versus negative expectancies among Eastern 
people. Eastern people have higher tolerance for ambivalence and little need to decide on a 
single side to take when processing conflicting information. As the supplement’s benefits and 
side effects are described separately in the ad, Eastern respondents would process the benefits 
and side effects separately. They would form their expectancies about benefits based on the 
benefits mentioned in the ad, and form their expectancies about side effects based on the side 
effects mentioned in the ad. Therefore, the increase in the risk information specificity and 
persuasiveness should only influence Eastern respondents’ expectations of side effects, and 
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not benefits. As benefit information remains the same between two conditions, Eastern 
people’s benefit expectancies about the supplement should remain the same. This asymmetry 
should not exist among Western people. Western people tend to decide on a single side to take 
based on double-sided information. Therefore, as risk information specificity increases, they 
should switch their side from positive to negative, causing benefit expectancies to decrease 
and side effect expectancies to increase.  
As explained in the Introduction, cultural differences in people’s expectancy over the 
supplement might be due to differences in people’s information processing style, instead of 
Western vs. Eastern geographic distinction. Therefore, I am also predicting an interaction 
between people’s dialectical thinking propensity and side effect information specificity on 
their expectancies of the supplement.  
People with lower dialectical thinking propensity tend to have lower tolerance for 
ambivalence, and should have stronger feelings of inconsistency when faced with conflicting 
information, which should result in more single-sided expectancies (in this case, the more 
persuasive side). As their tendency to engage in dialectical thinking increases, their tolerance 
for ambivalence should also increase, resulting in less feelings of inconsistency and more 
double-sided expectancies. Information specificity should moderate this effect.  
First, I consider participants’ expectancies about the benefits. When side effects are 
described in general, the positive information is more persuasive than negative information, 
and people would generally expect more positive effects. Therefore, people with different 
dialectical thinking propensity should not differ much in their positive expectancies. When 
the side effects are described in detail, the positive and negative information are at the same 
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level of specificity, but negative information should be perceived as more persuasive, as 
negative information tends to be more impactful than positive information (Baumeister et al., 
2001). People with lower dialectical thinking propensity should consider benefits in the ad 
information to be less likely than people with higher dialectical thinking propensity. This 
should cause a tendency that the more dialectically people think, the higher positive 
expectancies they form. 
H5: When the side effects are described in general, people different in their dialectical 
thinking style should have similar positive expectancies of the supplement. When the side 
effects are described in detail, the more dialectically people think, they will form more 
positive expectancies of the supplement.  
Next, I consider participants’ expectancies about side effects. When side effects are 
described in general, the side effects are much less persuasive compared to positive effects. 
Therefore, people who are lower in their dialectical thinking propensity should be influenced 
by this relative persuasiveness and expect fewer side effects to occur. The more dialectically 
people think, the less likely they will be influenced by the relative persuasiveness, and will 
separately process the double-sided information while making judgments. Therefore, the 
more dialectically people think, the more negative expectancies they will form. When the side 
effects are described specifically, the side effects are at the same level of specificity as the 
benefits, but should be more impactful (again, Baumeister et al., 2001) and therefore more 
persuasive. People should generally expect negative effects from the supplement. Therefore, 
in this specific side effect situation, people with different dialectical thinking styles should 
not differ much in their negative expectancies. 
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H6: When the side effects are described in general, the more dialectically people think, 
the higher negative expectancies of the supplement they will form. When the side effects are 
described in detail, people different in their dialectical thinking style should have similar 
negative expectancies of the supplement. 
Taken together, hypotheses 5 and 6 represent a predicted three-way interaction among 
two between-participants variables (dialectical thinking propensity and side effect 
information specificity) and one within-participants variable (expectancies about benefits and 
side effects).  
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CHAPTER 3: METHODOLOGY 
3.1 Pretest 
3.1.1 Participants and Design 
A pre-test was conducted to select appropriate elements to use in the pharmaceutical ad 
design for the main study1. In the pre-test, 64 participants responded to an online survey, with 
30 undergraduate students recruited from a large Midwestern university in the U.S., and 34 
undergraduate students recruited from a large university in China.  
3.1.2 Procedure 
The pre-test used a within-subject design. Two brand names and two photos for the ad 
were tested regarding their appropriateness and similarity to normal vitamin supplement ads 
on seven-point scales. Also, ten possible benefits of the vitamin supplement were tested 
regarding their likelihood of occurrence, helpfulness, and likelihood of taking place in 30 
minutes on seven-point scales. Ten possible side effects of the vitamin supplement were also 
tested regarding their likelihood of occurrence, unfavorability, and the likelihood of taking 
place in 30 minutes on seven-point scales. Then the formats for side effects were tested. Two 
versions of how side effect information would be presented were shown to participants. One 
version vaguely mentioned the possible discomfort using general terms, stating that “if you 
have any discomfort after taking the supplement,” whereas the other version clearly described 
                                                   
1 I also collected information about people’s predisposition towards medicine (Moss-Morris, Weinman, Petrie, 
Horne, Cameron, & Buick, 2002), but for the sake of brevity that information is not discussed in the main body 
any further. A copy of the pretest questionnaire including all questions asked of participants is in Appendix A.   
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the specific possible risks like “unnatural flush or swelling of your face, lips, tongue or 
throat.” (see Appendix A for detail) Participants’ perception of the specificity and 
appropriateness of the two versions of side effect descriptions were assessed. At the end, their 
basic demographic information was gathered.  
3.1.3 Results 
The results of the pre-test are as follows. Paired samples t-tests were conducted on the 
measures of brand names and photos. The brand name “Natural Lives” (M = 4.71, SD = 1.55) 
was perceived to be more appropriate than the name “Vegetation” (M = 3.73, SD = 1.58), 
tstudent (58) = 4.62, p < .001, d = .60. The name “Natural Lives” (M = 3.97, SD = 1.79) was 
also perceived to be more like other existing vitamin supplement brands on the market than 
the name “Vegetation.” (M =3.34, SD = 1.68), tstudent (58) = 2.49, p < .02, d = .32 .Therefore, 
“Natural Lives” was chosen as the product name for the main study. The first photo 
presenting a basket of fruits and vegetables (M = 5.56, SD = 1.42) was rated significantly 
more appropriate than the second photo presenting a man standing on top of a mountain (M = 
4.73, SD = 1.59), tstudent (58) = 3.15, p = .003, d = .41 (see Appendix A for the photos). The 
first photo (M = 5.73, SD = 1. 60) was also significantly more similar to other vitamin 
supplement ads, compared to the second photo (M =4.34, SD = 1.68), tstudent (58) = 3.69, p 
< .001, d = .48. Therefore, the first photo was chosen for the main study.  
For the ten appeals of the vitamin supplements’ benefits, the mean scores of their 
likelihood of occurrence, helpfulness and likelihood of occurring in 30 minutes were 
compared (see Appendix C Table 3 for means and standard deviations). As this paper 
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concerns placebo/nocebo effects, the seven benefits that were rated highest in the likelihood 
of occurring in 30 minutes were selected for the main study. The scores of these seven 
benefits on the other two measures were also checked, and none of them has the lowest score 
in the other two measures. For the ten side effects, the four side effects that were rated highest 
in the likelihood of occurring in 30 minutes were selected for the main study. The scores of 
these four side effects on the other two measures were also checked, and none of them had 
the lowest score in the other two measures (see Appendix C Table 4 for means and standard 
deviations).  
Paired samples t-tests were conducted to test the perceived specificity of the two versions 
of side effect descriptions. The specific one (M = 5.83, SD = 1.21) was rated significantly 
higher in specificity than the general one (M = 2.71, SD = 1.57), tstudent (58) = -11.72, p 
< .001, d = -1.53. There was no difference between the perception of the appropriateness of 
the specific (M = 4.95, SD = 1.82) and general (M = 5.27, SD = 1.38) side effect information, 
tstudent (58) = 1.29, p = .204, d = 0.17.  
3.2 Main Study 
3.2.1 Participants and Design 
 One hundred forty-two people participated, 78 of them undergraduate students recruited 
from a large Midwestern university in the U.S. (representing Western culture), and 64 of them 
undergraduate students recruited from a large university in China (representing Eastern 
culture). The study used a 2 (cultural background: Western vs. Eastern) x 2 (side effect 
information specificity: specific vs. general) (x 2 (expectancy: benefits and side effects)) 
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mixed, quasi-experimental design. The culture and specificity were between-participants 
variables, and expectancy was a within-participants variable. For both cultural groups, 
participants were randomly assigned to one of the two side effects information specificity 
conditions. 
3.2.2 Procedure 
A Chinese experimenter conducted all sessions. Participants were seated in a classroom, 
gave consent to participate in the study, and were then given a questionnaire booklet. 
Participants were instructed that they would first read a pharmaceutical ad for a vitamin 
supplement that was going to be launched to the market soon, then asked to answer some 
questions about their evaluation of the ad as well as their own information processing styles, 
then take the advertised vitamin supplements and report their physical feelings. The last two 
steps in this process (taking a vitamin supplement and reporting physical feelings) did not 
actually take place; they were intended to make participants immersed into the situation, so 
that they would consider the information and answer the questions thoughtfully. Following 
these instructions, everyone read the pharmaceutical ad, which contained the side effect 
specificity manipulation. Then they were asked about their expectancies for the benefits and 
side effects of the vitamin supplement to occur, also their expectancy for the supplement’s 
outcome to be beneficial and harmful2. Participants then finished the questionnaires 
indicating their perception of how specific the side effects mentioned in the ads were (a 
                                                   
2 Participants were also asked to list their thoughts about these ads then code their thoughts as positive, neutral 
or negative. However, more than half of the participants from China didn’t code their thoughts themselves, so 
this measure was abandoned in the analyses. For the sake of brevity that information is not discussed any 
further. 
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manipulation check), and completed a measure of their dialectical thinking propensity3, 4. 
They were thanked and debriefed about the purpose of this experiment in the end. 
3.2.3 Independent Variables 
Cultural background. Western participants were recruited from a large sample pool of 
undergraduate students majoring in Advertising at the University of Illinois in the U.S.. 
Eastern participants were recruited from a sample of undergraduate students registering for 
the class “Advertising Strategies” in Wuhan University in China. This allowed for a quasi-
experimental study on the effect of cultural backgrounds on responses to the stimuli. 
Side Effect Information Specificity. To manipulate the specificity of the side effect 
information, two versions of vitamin supplement ad were created. For the high specificity 
condition, side effects were described in detail. For example, “if it causes slight stomach ache 
due to the acidic ingredient, unusual or unpleasant taste in your mouth, unnatural flush, or 
appetite loss, please consult your physician for further instruction.” For the low specificity 
group, side effects were described vaguely without mentioning what exact feelings would 
people have after taking the supplement. For example, “if you feel uncomfortable with your 
stomach or mouth, or have any other unpleasant feelings after taking this, please consult your 
physician for further instruction.” All the other information remained identical in these two 
conditions, which also includes seven benefits and other necessary elements in an ad. The 
                                                   
3 Data were also collected on people’s predisposition towards medicine using the same scale as in the pretest, 
but for the sake of brevity that information is not discussed any further.  
4 Data were also collected on people’s holistic vs. analytic processing orientation, using the 24-item AHS scale 
developed by Choi, Koo & Choi (2007), but the four-factor solution presented in Choi et al. (2007) shows poor 
fit in the confirmatory factor analysis and is therefore not discussed any further in the result section. Please see 
Appendix D for more detail. 
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copy of the ads was written in the native language in both cultures, as Chinese participants 
read a Chinese version and U.S. participants read an English version; the content remained 
equivalent between two cultures. 
3.2.4 Dependent Measures 
Expectancies. Participants’ expectancies towards the vitamin supplements’ effects were 
assessed in four questions. Two questions measured the likelihood participants expect to 
experience the benefits and side effects mentioned in the ads on five-point scales, ranging 
from extremely unlikely to extremely likely. For these two questions, higher scores indicate a 
higher expectancy of experiencing the effects. One question measured participants’ 
expectancy for the outcome of taking the supplement to be beneficial, using a five-point scale 
ranging from beneficial to neutral, and the last one question measured participants’ 
expectancy for the outcome of taking the supplement to be harmful, using a five-point scale 
ranging from harmful to neutral. For the last two questions, the scores were reversed, and 
higher scores indicate a higher expectancy for the outcome to be beneficial/harmful. The 
question asking about people’s expectancies of benefits, and the question asking about 
people’s expectancy for the outcome of taking the supplement to be beneficial, were both 
intended to measure people’s positive expectancies, and would be collapsed into one in the 
analysis. The question asking about people’s expectancies of side effects, and the question 
asking about people’s expectancy for the outcome of taking the supplement to be harmful, 
were both intended to measure people’s negative expectancies, and would also be collapsed 
into one in the analysis. 
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Dialectical Thinking Propensity. The Dialectical Self-Scale (DSS) (Spencer-Rodgers, 
Srivastava, Boucher, English, Paletz, & Peng, 2015) was administered. Participants indicated 
the extent to which they agreed with each of the statements (e.g., “I am the same around my 
family as I am around my friends” and “When I hear two sides of an argument, I often agree 
with both”), rating on a seven-point scale ranging from strongly disagree to strongly agree. 
Higher scores on this scale indicate a more dialectical thinking style (See Appendix B for full 
scale). 
Manipulation Check. The manipulation check for side effect specificity was measured 
by asking participants to evaluate the perceived specificity of the side effects mentioned in 
the ads on a five-point Likert-type scale, ranging from general to detailed. Higher scores 
reflect more detailed information. I also checked whether participants stayed in their current 
cultures for more than 3 years. 
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CHAPTER 4: RESULTS 
4.1 Manipulation Check.  
Seven participants from Western culture group were excluded from the results, as they 
hadn’t yet stayed in their current culture for 3 years, and should not be considered good 
subjects of the cultural influence. In line with the intended manipulation, participants who 
saw the specific side effect information (M = 3.09, SD = 1.39) rated the ads as being more 
specific than participants who saw the general side effect information (M = 1.84, SD = 1.24), 
twelch (128) = -5.51, p < .001, d = 0.95 (Delacre, Lakens, & Leys, 2017).  
4.2 Descriptive Analyses 
 Means, standard deviations, ranges, and reliability statistics of the variables measured in 
the study are presented in Table 1. 
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Table 1 
4.3 Relationships Among Variables 
 Relationships among participants’ dialectical thinking propensity and dependent 
variables of participants’ expectancies towards the nutritional supplement are in Table 2. The 
correlation matrix shows that participants’ expectancy of the supplement having benefits was 
significantly correlated with the extent to which participants expected taking the supplement 
Variable Mean SD Possible 
range 
Alpha 
 Western Eastern Total  Western Eastern Total   
Positive 
effect 
expectancy 
3.38 3.12 3.26 1.03 0.98 1.01 1 to 5 
 
Negative 
effect 
expectancy 
2.59 2.46 2.53 0.92 1.03 0.97 1 to 5   
Beneficial 
outcome 
3.00 2.69 2.85 1.40 1.26 1.34 1 to 5   
Harmful 
outcome 
1.69 1.66 1.68 0.95 1.07 1.00 1 to 5   
Dialectical 
thinking 
propensity 
4.15 4.31 4.23 0.47 0.43 0.45 2.88 to 
6.00 
 0.685 
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to be beneficial (r = 0.375, p < 0.001). Participants’ expectancy of supplements having side 
effects was significantly correlated with belief about the supplement being harmful (r = 
0.297, p = 0.001). Given that the two questions of participants’ positive expectancies, and the 
two questions of participants’ negative expectancies were significantly correlated (although 
not as high as hoped), I collapsed them into two measures: one reflecting positive 
expectancies, and the other reflecting negative expectancies.  
 
 
Table 2 
 
4.4 Tests of Hypotheses 
4.4.1 Three-way mixed ANOVA: effect of Culture by Side Effect Information Specificity 
by Expectancy Type on Expectancies 
Participants’ expectancies of the supplement’s effects were examined using a* Title each 
appendix with a title that describes its contents and add the title to the table of contents. 2 
(Culture: Western or Eastern) x 2 (Side Effect Information Specificity: General or Specific) 
(x (2 Expectancy Type: Positive or Negative)) mixed three-way ANOVA; culture and 
specificity were between-participants variables, and expectancy type was a within-
Positive effect 
expectancy
Negative effect 
expectancy
Beneficial 
outcome 
expectancy
Harmful 
outcome 
expectancy
Negative effect expectancy -0.074
Beneficial outcome expectancy **0.375 0.088
Harmful outcome expectancy -0.063 **0.297 0.161
Dialectical thinking propensity 0.150 0.076 0.136 -0.033
Note:
*p<.05
**p<.01
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participants variable. This analysis revealed a main effect for expectancy type. People 
expected more positive effects (M = 3.05, SD = .99) than negative effects (M = 2.11, SD 
= .81), F(1, 118) = 67.701, p < .001, = .365. There was no main effect for culture: 
Western people (M = 2.66, SD = .64) and Eastern people (M = 2.49, SD = .67) did not differ 
in mean expectancy scores, F (1, 118) = 1.99, p = .16, = .017. This main effect is 
relatively uninterpretable, though, as the dependent measure is the combined mean of positive 
and negative expectancies, which theoretically reflects how much people expect the 
supplement have an effect in either positive or negative directions. Hereafter, similarly 
uninterpretable dependent measures, where positive and negative expectancies are combined 
into a single dependent measure, will be noted, “(uninterpretable).” There was no main effect 
for side effect information specificity: Participants who saw general side effect information 
(M = 2.57, SD = .68) and participants who saw specific side effect information (M = 2.59, 
SD = .65) did not differ in mean expectancy scores (uninterpretable), F (1, 118) = .004, p 
= .95, = .000 
 H1 proposed an expectancy type by side effect information specificity interaction, that 
people would have higher expectancies of benefits than side effects in the general condition, 
and higher expectancies for side effects than benefits in the specific condition. However, 
according to the results, there was no interaction between expectancy type and side effect 
information specificity, F (1, 118) = .21, p = .65, = .002. People who saw specific side 
effect information and people who saw general side effect information did not differ in either 
positive or negative expectancies for the supplement. H1 was not supported. Besides the 
testing of H1, there was no interaction between expectancy type and culture, either, F (1, 118) 
hp
2
hp
2
hp
2
hp
2
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= .70 p = .41, = .006. People from Western and Eastern cultures did not differ in either 
positive or negative expectancies for the supplement. There was no interaction between 
cultures and side effect information specificity on participants’ expectancies for the 
supplement (uninterpretable), F(1, 118) = 2.05, p = .16, = .017.  
H4 predicted that there should be a three-way interaction of culture by side effect 
information specificity by expectancy type. However, culture by side effect information 
specificity by expectancy type three-way mixed ANOVA analysis was not significant, F 
(1,118) = .11, p = .75, = .001 (see Figures 4 and 5). H4 was not supported. 
In order to test H2 and H3, which predicted how people from Western vs. Eastern 
cultures should be influenced by side effect information differently and form positive and 
negative expectancies differently, I decomposed the three-way into separate two-way culture 
by side effect information specificity interactions: one for positive expectancies, and another 
for negative expectancies.  
4.4.2 Two-way ANOVA: effect of Culture by Side Effect Information Specificity on 
Expectancies 
H2 predicted a culture by side effect information specificity interaction on positive 
expectancies, such that cultural difference on people’s positive expectancies should only 
emerge when the side effects are described in detail, but not when they are described in 
general. In order to test H2, I conducted a two-way factorial ANOVA with culture and side 
effect specificity as the independent variables and participants’ positive expectancies of the 
supplement as the dependent measure (see Figure 4). There was no main effect of 
participants’ cultural backgrounds: American (M = 3.19, SD = .98) and Chinese (M = 2.91, 
hp
2
hp
2
hp
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SD = .96) participants did not differ in their positive expectancies of the supplement, F(1, 
130) = 2.99, p < .09, = .022. There was no main effect of the side effect information 
specificity, either: participants who saw general side effect information (M = 3.08, SD = 1.00) 
and participants who saw specific side effect information (M = 3.03, SD = .96) did not differ 
in their positive expectancies of the supplement, F(1, 130) = .11, p = .74, = .001. There 
was no significant interaction between cultural background and side effect information 
specificity, F(1, 130) = 0.67, p = .41, = .005. In either general risk information condition 
or specific risk information condition, there was no difference between American and 
Chinese people’s positive expectancies for the supplement’s effects. H2 was not supported. 
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2
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Figure 4. Mean positive expectancy as a function of culture and side effect information 
specificity. Standard errors are represented in the figure by the error bars attached to each 
column.  
H3 predicted a culture by side effect information specificity interaction on negative 
expectancies, such that cultural differences in people’s negative expectancies should only 
emerge when the side effects are described in detail, but not when they are described in 
general. In order to test H3, I conducted another two-way factorial ANOVA with cultural 
background and side effect specificity as the independent variables and participants’ negative 
expectancies of the supplement as the dependent measure (see Figure 5). There was no main 
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effect of participants’ cultural background: American (M = 2.14, SD = 0.77) and Chinese (M 
= 2.08, SD = .85) participants did not differ in their negative expectancies of the supplement, 
F (1, 120) = 0.19, p = .67,  = .002. There was no main effect of the side effect 
information specificity: Participants who saw general side effect information (M = 2.08, SD 
= .77) and participants who saw specific side effect information (M = 2.15, SD = .84), did not 
differ in their negative expectancies of the supplement, F(1, 120) = 0.11, p = .74, = .001). 
There was no significant interaction between cultural background and side effect information 
specificity, F (1, 120) = 2.07, p = .15,  = .017. In either general risk information 
condition or specific risk information condition, there was no difference between American 
and Chinese people’s negative expectancies for the supplement. H3 was not supported.  
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Figure 5. Mean negative expectancy as a function of culture and side effect information 
specificity. Standard errors are represented in the figure by the error bars attached to each 
column.  
As discussed in the Introduction, culture is an insensitive measure of processing 
differences. A more sensitive measure of processing differences in the current contradictory 
information situation, is a measure that directly assesses dialectical thinking propensity, such 
as the DSS (Spencer-Rodgers et al., 2015). I identified and removed seven outliers that 
ranged above and below the 1.5 times interquartile (IQR) of people’s mean score on DSS 
scale, using Tukey’s method (Dhana, 2016). After the outliers were removed, the result 
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showed that American participants (M = 4.16, SD = .32) were less dialectical than Chinese 
participants (M = 4.29, SD = 0.38), twelch (123) = 2.09, p < .04, d = -0.370. (Delacre et al., 
2017). However, this difference was not very large; many American participants had higher 
dialectical thinking scores than Chinese participants (see Figure 6). To use this more sensitive 
measure of dialectical thinking, I replaced cultural background with people’s dialectical 
thinking propensity and conducted regression analyses to test whether the dialectical thinking 
propensity by side effect information specificity interacted to predict participants’ positive 
and negative expectancies of the supplement’s effects. 
=  
Figure 6 
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4.4.3 Regression Analysis: effect of Dialectical Thinking Propensity by Side Effect 
Information Specificity on Expectancies 
H5 predicted a dialectical thinking propensity by side effect information specificity 
interaction on people’s positive expectancies, such that higher dialectical thinking propensity 
should be correlated with higher positive expectancy only when the side effects are described 
in detail, but not when they are described in general. In order to test H5, multiple regression 
was conducted to test if participants’ dialectical thinking propensity together with the side 
effect information specificity predicted their positive expectancies for the supplement (see 
Figure 7). People’s dialectical thinking propensity was not significantly related to their 
positive expectancies of the supplement, β = .50, p = .18. There was no main effect of side 
effect information specificity on positive expectancies, either: β = 1.04, p = .62. There was no 
interaction between dialectical thinking propensity and side effect information specificity on 
positive expectancies: β = -.25, p = .61. The two predictors were not significantly related to 
positive expectancies, and they explained 1.9% of the variance of people’s positive 
expectancies for the supplement (F(3,122) = .80, p = .50, R2=.019, R2adjusted = -.005). H5 was 
not supported. 
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Figure 7 
H6 predicted a dialectical thinking propensity by side effect information specificity 
interaction on people’s negative expectancies, such that higher dialectical thinking propensity 
should be correlated with higher positive expectancy only when the side effects are described 
in general, but not when they are described in detail. In order to test H6, a multiple regression 
was conducted to test if participants’ dialectical thinking propensity together with the side 
effect information specificity predicted their negative expectancies for the supplement (see 
Figure 8). There was no main effect of people’s dialectical thinking propensity: β = -.29, p 
= .35, meaning that people’s dialectical thinking propensity was not significantly related to 
their negative expectancies of the supplement. There was no main effect of side effect 
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information specificity either: β = -1.69, p = .35, meaning that people from different 
specificity groups did not differ in their negative expectancies. There was no interaction 
between dialectical thinking propensity and side effect information specificity on positive 
expectancies: β = .39, p = .36. The two predictors were not significantly related to people’s 
negative expectancies, and they explained 1 % of the variance of people’s negative 
expectancies for the supplement (F(3,113) = 0.37, p = .78, R2=.01, R2adjusted = -.017). H6 was 
not supported. 
 
Figure 8 
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CHAPTER5: DISCUSSION 
5.1 Findings 
This paper focuses on a potential cultural difference: people from different cultures might 
experience placebo/nocebo effects differently. I used people’s expectancies of the 
supplement’s effects as a measure to reflect the possible magnitude of placebo/nocebo 
effects, because expectancy is demonstrated to be a determinant of the placebo/nocebo effects 
(Montgomery & Kirsch, 1997). I hypothesized that a cultural difference in tolerance for 
inconsistency might influence the way people process inconsistent information contained in a 
pharmaceutical ad. I found that Chinese participants are more dialectical than American 
participants in their cognitive processing style, indicating that Chinese participants tend to 
have higher tolerance for ambivalence when processing conflicting information, compared to 
American participants.  
However, none of the hypotheses were supported. In the three-way interaction of culture 
by side effect information specificity by expectancy type, the only significant result is the 
main effect of expectancy type, as people have higher expectancies for positive effects than 
negative effects. An interaction emerged between participants’ cultural backgrounds and the 
specificity of side effect information on the combined score of their positive and negative 
expectancies. However, this is uninterpretable, because it can only be seen as a reflection of 
the general level of how participants were persuaded that the supplement had an effect, 
instead of how they expect of positive and negative effects.   
In addition to the failure to find a cultural difference on people’s expectancies towards 
the supplement under both general and specific risk information conditions, I didn’t find any 
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relation between people’s dialectical thinking propensity and their expectancies towards the 
drug.  
Besides dialectical thinking propensity, holistic vs. analytic thinking style was also 
measured in the experiment as a proxy to reflect cultural differences. The original 24-item 
scale was developed on four factors, causality, attitude toward contradiction, perception of 
change, and locus of attention (Choi & Choi, 2007). The second factor, “attitude toward 
contradiction” is the most relevant one to the current problem of contradictory information 
processing, and was meant be the cultural trait that is responsible for people’s behavioral 
outcome of pharmaceutical ad information processing..  
There are several possible reasons why my hypotheses were not supported. It is possible 
that cultural differences might not extend into people’s pharmaceutical information 
processing. People from Eastern and the Western cultures scored differently on their 
dialectical thinking style. However, this might only reflect the difference in people’s 
declarative knowledge of how much they believe they can tolerate ambivalence, but not in 
how they systematically process conflicting information. People from both Eastern and 
Western cultures might process information similarly (if not identically), and thus form 
similar expectancies towards the drug. 
Besides the faulty hypotheses, another possibility is that the stimuli failed to elicit the 
effects as intended. For example, it is possible that participants’ previous knowledge about 
vitamin supplements already provides them with a prediction that vitamin supplements are 
not “risky.” Therefore, regardless of what was mentioned in the ad, they might feel that it was 
not easy to experience the effects, causing floor effects in the results. This being the case, 
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even if they processed the double-sided information differently and went through different 
levels of ambivalent feelings, there was still not much room for them to diversify in their 
expectancies of how benefits and harms would occur. 
In this study, I also measured people’s predisposition toward medicine in general. It is 
possible that what people believe about benefits and harms of medicine, in general, could 
influence how they form expectancies about the vitamin supplement after reading the ad. 
Similarly, I also measured people’s thoughts generated after reading the ad. This could later 
be used as an index of how dialectical they thought before forming expectancies. Also, I 
measured people’s cultural orientations of holistic versus analytic processing styles as a 
supplement to the dialectical thinking propensity. It is possible that the “attitude toward 
contradiction” sub-scale in the holistic versus analytic thinking scale is a more influential 
predictor of people’s expectancies than dialectical thinking style. However, as the measure 
showed poor fit in the confirmatory factorial analysis, furture research and data collection is 
needed in testing its predictive power on people’s expectancies.  
There might be concern that pharmaceutical ad information represents a form of 
refutational information. Research has demonstrated that when faced with refutational 
information with one side more persuasive than the other, the stronger side could be 
perceived to have even greater credibility and persuasiveness, at a sacrifice of the perceived 
credibility and persuasiveness of the weaker side. However, a meta-analysis showed that it 
only exists when the information is on a non-advertising topic (O’Keefe, 1999). Therefore, 
this factor was not taken into consideration in the current study. 
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One of the implications of this study is that it enlarges the scope of the study of cultural 
differences by addressing the possibility that people from different cultures may widely differ 
in their ways of information processing, which could then lead to various behavioral 
consequences. Specifically, in this paper, I studied the cultural difference in people’s 
processing of conflicting information in pharmaceutical ads, which is supposed to lead to 
placebo/nocebo effects (Montgomery & Kirsch, 1997). Though people’s differences in 
tolerance for ambivalence didn’t lead them to process the pharmaceutical information 
differently and thereby form different expectations towards supplements, this research opens 
a door to more explorations on behavioral outcomes of cultural influence. Also, in this study I 
looked into this issue from the perspective of information processing, instead of directly 
linking general cultural traits (for example, geographic Eastern versus Western) to the final 
behavioral outcomes. Therefore, I made an attempt to provide a deeper explanation of why 
people in different cultures form expectancies differently. However, possibly due to the 
inappropriate use of stimuli or cultural orientation scales, the attempt was not successful. 
Another contribution of this paper is that it addresses the need to consider placebo and 
nocebo effects (the proportion of the effects caused by individual’s psychological influences) 
when doing drug ad design or instruction design. The pharmaceutical advertising industry 
might also need to consider how cultural background functions in this ad induced 
placebo/nocebo effects. If further research shows that people process the ad information 
differently and generate different levels of expectations, different ways of communication 
might be needed to suit different cultures. When the aim is to minimize consumers’ worries 
about side effects, practitioners may need to convey side effects in more general terms in 
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markets where people have higher tolerance for ambivalence because they are more sensitive 
to both positive and negative sides of the information. Therefor they might need a milder alert 
to mitigate excessive worries. If the purpose is to alert users about the possible side effects, 
more specific side effect information might be needed for markets where people have lower 
tolerance for ambivalence and are relatively insensitive to side effects information, because 
they might need a stronger strike to be alert. 
5.2 Limitations and Future Research 
However, there are some limitations of this study. First, choosing vitamin supplements 
among all the drugs to elicit placebo/nocebo effects might limit the power of those effects. 
Though categorized as a type of drug, vitamin supplements usually have mild effects and 
people are familiar with them as a daily dietary supplement. This could cause people’s 
expectancies for benefits and side effects to remain at a mild level. In future study, 
researchers could change the drug type in order to elicit more polarized expectancies about 
benefits and harms. 
Second, the manipulation of the side effect information specificity needs improvement. 
The influence of side effect information specificity might be confounded with the influence 
of the number of side effects listed in the ad. The specific condition has four side effects 
described in detail, while the general condition only has the first two side effects vaguely 
mentioned, and a general sentence stating “discomfort” instead of a specific part of the body 
where discomfort might take place. It is possible that it is the number of side effects that 
cause the difference between the two side effect information conditions, that more side effects 
lead to the possible effects, instead of the intended manipulation of information specificity. 
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Third, the measurement of two pairs of dependent variables – people’s expectancy about 
the supplement’s benefits and side effects, and the extent to which people expect the outcome 
of taking the supplement to be beneficial and harmful, failed to show high correlation. 
Though I combined them into one pair of measures as there were significant correlations, 
with the two measures of positive expectancies correlated at 0.38, and the two measures of 
negative expectancies correlated at 0.30, it is possible that participants comprehended the two 
measures in the same direction differently. I might have sacrificed the validity of the 
measures for brevity and comprehensibility of the paper by collapsing them. However, as it 
remains unclear how people understand two pairs of measures differently, I don’t know 
which one pair would be a better reflection of what I want to measure, thus there might be a 
problem with construct validity of the measures. 
Fourth, the measure of people’s dialectical thinking style using the DSS scale is still in a 
developmental stage (Spencer-Rodgers et al., 2015). Though it has been adopted in many 
studies (e.g., Chen, Benet‐Martínez, Wu, Lam, & Bond, 2013; Spencer-Rodgers et al., 2009), 
the validity is still not guaranteed especially in predicting people’s information processing 
style, as the scale was originally developed in the domain of self-perception (Spencer-
Rodgers et al., 2015).  
Fifth, cultural differences in response to the ad, which I did not control for or measure, could 
be responsible for the expectancy difference between Eastern and Western participants. There 
are several things included. First, there might be a difference in vitamin supplement 
consumption between the U.S. and China. This might cause people from these two cultures to 
have different familiarity with, as well as feelings toward, vitamin supplements. Thus the 
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difference in expectations as well as feelings towards the ad might be due to people’s 
familiarity with the ad. Second, the design of ads are usually different between two cultures. 
To remain equivalent, here in this study I adopted a single style in the two cultural groups. 
However, the style adopted in this study might be more in line with the Western style, which 
is relatively simple, and might cause different feelings among Western participants compared 
to Eastern participants. Third, pharmaceutical advertisement regulations are different between 
two countries, as the U.S. allows direct-to-consumer (DTC) drug ads while China doesn’t, 
reflecting a higher tolerance for drug advertisements in the U.S. than in China. This could 
result in a difference in participants’ familiarity with pharmaceutical ads, causing their 
sensitivity to benefit and side effect information to be different. Fourth, people from Western 
and Eastern cultures are also believed to have different levels of uncertainty avoidance, which 
results in different sensitivity to risk information (e.g., Bontempo, Bottom, & Weber, 1997). 
Therefore, in this study, the same expression of risks in two cultural groups might have 
caused different levels of alertness among people from different cultures, influencing their 
perception and inferences of the information. Fifth, most studies testing information 
specificity’s influence on persuasiveness were done in Western cultures (e.g., Leventhal, 
Singer & Jones, 1965). However, Eastern people are believed to be more holistic, so that they 
don’t necessarily perceive the persuasiveness of the information based on its specificity in the 
same ways as Western people do. For example, they might not rely on the information’s 
specificity to evaluate its persuasiveness the same way as Western people do, as they have 
lower need to use explicit rules and structures to make inferences about things or information 
(Peng & Nisbett, 1999). Therefore, the observed cultural difference in people’s expectancies 
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of the supplement may be due not only to the difference in how people deal with 
contradictory information, but also to the difference in perceived persuasiveness of the two 
sides of the information. Finally, as mentioned by Faasse and Petrie (2013), there is another 
factor influencing nocebo effects that I didn’t include: the individual sensitivity to side 
effects. It refers to a general belief of being particularly sensitive to medications, usually 
caused by previous negative experiences of side effects. For future study, researchers can test 
whether the perceived sensitivity differs across cultures, and how it could affect how people 
form their expectations and experience placebo/nocebo effects. 
 For further exploration on this topic, research could also be done to let participants take 
the placebo, so that we can test how this potential cultural difference in people’s information 
processing could also affect people’s physical feelings, as a full demonstration of placebo and 
nocebo effects.  
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APPENDIX A: PRE-TEST QUESTIONNAIRE 
We are testing the elements for a vitamin supplement ad. Please answer the following 
questions. 
1. How appropriate is "Natural Lives" as the name for a vitamin supplement?  
|  Extremely inappropriate  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely appropriate | 
2. How familiar is "Natural Lives" as the name for a vitamin supplement? 
|  Extremely unfamiliar  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely familiar | 
3. How appropriate is "Vegetation" as the name for a vitamin supplement? 
|  Extremely inappropriate  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely appropriate | 
4. How familiar is "Vegetation" as the name for a vitamin supplement? 
|  Extremely unfamiliar  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely familiar | 
 
Consider using the picture below as the visual in the ad. 
  
5. How appropriate is using this visual in a vitamin supplement ad? 
|  Extremely inappropriate  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely appropriate | 
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6. How similar is this visual to other vitamin supplement ad visuals you have seen? 
|  Extremely unfamiliar  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely familiar | 
 
Consider using the picture below as the visual in the ad. 
 
7.  How appropriate is using this visual in a vitamin supplement ad? 
|  Extremely inappropriate  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely appropriate | 
8. How similar is this visual to other vitamin supplement ad visuals you have seen? 
|  Extremely unfamiliar  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely familiar | 
 
Consider the following information about the side effects in the ad: 
If you have any discomfort after taking the supplement, please consult your 
physician for further instruction. 
9. How appropriate is the information about the side effects? 
|  Extremely inappropriate  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely appropriate | 
10. How detailed is the information about the side effects? 
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|  General  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Detailed  | 
 
Consider the following information about the side effects in the ad: 
If it causes unnatural flush or swelling of your face, lips, tongue or throat, please 
consult your physician for further instruction. 
11. How appropriate is the information about the side effects? 
|  Extremely inappropriate  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely appropriate | 
12. How detailed is the information about the side effects? 
|  General  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Detailed  | 
 
13. How likely is it that vitamin supplements in general can provide following benefits? 
|  Extremely unlikely  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely likely  | 
1) Provide essential nutrients that are important for proper retinal function  
2) Helps to filter harmful blue light 
3) Aids in the conversion of food into energy  
4) Aid metabolism of fats, carbohydrates and proteins  
5) Enhance immune defense  
6) Help maintain healthy appearance 
7) Protect the body’s cells from potential oxidative damage  
8) Helps with mental clarity and focus  
9) Helps support blood flow to the brain  
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10) Helps support neurotransmitters used by the body to improve healthy brain function 
  
 
14. How useful is the vitamin supplement for helping the following medical issues?  
|  Extremely useless  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely useful  | 
 (the same items as Question 13) 
 
15. How likely is it that vitamin supplements in general will cause following side effects? 
|  Extremely unlikely  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely likely  | 
1) Causing slight stomachache due to the acidic ingredient 
2) Difficulty breathing 
3) Swelling of your face, lips, tongue or throat 
4) Nausea 
5) Headache 
6) Unnatural flush 
7) Fast or irregular heartbeat 
8) Unusual or unpleasant taste in your mouth 
9) Appetite loss 
10) Feeling of fever 
 
16. What do you think of the following risks of the vitamin supplement? 
|  Extremely unfavorable  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Not unfavorable  | 
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  (the same items as Question 15) 
 
17. In general, how likely is it that following effects occur within 30 minutes of taking 
vitamin supplements? 
(the same items as Question 13 + 15) 
|  Extremely unlikely  | 1 | 2 | 3 | 4 | 5 | 6 | 7 |  Extremely likely  | 
 
18. Using the scale below, select the number that best matches your level of agreement or 
disagreement with each statement. There are no right or wrong answers. 
1---------------2---------------3---------------4---------------5---------------6---------------7 Strongly 
disagree      Neither agree nor disagree           Strongly agree      There is very 
little that a medicine can do to improve health condition 
1) Medicine will be effective in curing illness 
2) Medicine can control illness 
3) There is nothing which can help with sick condition 
4) Health, at present, depends on my medicines 
5) Life would be impossible without medicines 
6) Without medicines people would be very ill 
7) People’s health in the future will depends on medicines 
8) Medicines protect people from becoming worse 
9) People who take medicines should stop their treatment for a while every now and again 
10) Most medicines are addictive 
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11) Medicines do more harm than good 
12) All medicines are poisons 
13) Having to take medicines worries me 
14) I sometimes worry about long-term effects of medicines 
15) Medicines are a mystery to me 
16) Medicines disrupt my life 
17) I sometimes worry about becoming too dependent on medicines 
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APPENDIX B: MAIN STUDY QUESTIONNAIRE 
Please read the following vitamin supplement ad and answer the following questions. 
 
Detail Group-English version 
 
General Group-English version 
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Detail Group-Chinese version 
 
General Group-Chinese version 
 
1. If you take this vitamin supplement, how likely is it that you will experience benefits? 
|  Extremely unlikely  |  1  |  2  |  3  |  4  |  5  |  Extremely likely  | 
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2. If you take this vitamin supplement, how likely is it that you will experience side effects? 
|  Extremely unlikely  |  1  |  2  |  3  |  4  |  5  |  Extremely likely  | 
 
3. Choose the number on each scale that best describes your expectation for the outcome of 
taking this vitamin supplement. 
| Harmful  |  1  |  2  |  3  |  4  |  5  | Neutral | 
| Beneficial |  1  |  2  |  3  |  4  |  5  | Neutral | 
 
4. Please list all the thoughts you have regarding the effect of the vitamin supplement while 
reading the ads just now. You will have 3 minutes to list your thoughts.  
1) _______________________________________________________ 
2) _______________________________________________________ 
3) _______________________________________________________ 
4) _______________________________________________________ 
5) _______________________________________________________ 
6) _______________________________________________________ 
7) _______________________________________________________ 
8) _______________________________________________________ 
9) _______________________________________________________ 
10) _______________________________________________________ 
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5. Please categorize your thoughts in the last question into 3 categories: favorable, neutral 
and unfavorable. Place a plus (+) next to the thoughts that are favorable, a minus (-) next 
to the thoughts that are unfavorable, and a zero (0) next to the thoughts that are neutral or 
irrelevant.  
 
6. How detailed is the information in the ad about side effects of the vitamin supplement? 
|  General  |  1  |  2  |  3  |  4  |  5  |  Detailed  | 
 
7. Using the scale below, select the number that best matches your level of agreement or 
disagreement with each statement. There are no right or wrong answers. 
1-------------2-------------3-------------4-------------5-------------6-------------7  
Strongly disagree    Neither agree nor disagree           Strongly agree       
1) There is very little that a medicine can do to improve health condition  
2) Medicine can control illness                       
3) There is nothing which can help with a person’s sick condition  
4) I sometimes worry about long-term effects of medicines  
5) My health, at present, depends on my medicines          
6) Life would be impossible without medicines         
7) Without medicines people would be very ill          
8) I sometimes worry about becoming too dependent on medicines 
9) People’s health in the future will depend on medicines  
10) Medicines protect people from becoming worse       
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11) People who take medicines should stop their treatment for a while every now and again 
12) Most medicines are addictive                       
13) Medicines do more harm than good 
14) Medicine will be effective in curing illness 
15) All medicines are poisons 
16) Having to take medicines worries me 
17) Medicines are a mystery to me 
18) Medicines disrupt my life 
 
8. Using the scale below, select the number that best matches your level of agreement or 
disagreement with each statement. There are no right or wrong answers. 
1-------------2-------------3-------------4-------------5-------------6-------------7  
Strongly disagree    Neither agree nor disagree           Strongly agree       
1) I am the same around my family as I am around my friends. 
2) When I hear two sides of an argument, I often agree with both. 
3) I believe my habits are hard to change. 
4) I believe my personality will stay the same all of my life. 
5) I often change the way I am, depending on who I am with.    
6) I often find that things will contradict each other. 
7) If I’ve made up my mind about something, I stick to it. 
8) I have a definite set of beliefs, which guide my behavior at all times.  
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9) I have a strong sense of who I am and don’t change my views when others disagree with 
me.                                              
10) The way I behave usually has more to do with immediate circumstances than with my 
personal preferences.                                                
11) My outward behaviors reflect my true thoughts and feelings.      
12) I sometimes believe two things that contradict each other. 
13) I often find that my beliefs and attitudes will change under different contexts. 
14) I find that my values and beliefs will change depending on who I am with. 
15) My world is full of contradictions that cannot be resolved. 
16) I am constantly changing and am different from one time to the next. 
17) I usually behave according to my principles. 
18) I prefer to compromise than to hold on to a set of beliefs. 
19) I can never know for certain that any one thing is true.      
20) If there are two opposing sides to an argument, they cannot both be right.  
21) My core beliefs don’t change much over time.  
22) Believing two things that contradict each other is illogical.  
23) I sometimes find that I am a different person by the evening than I was in the morning. 
24) I find that if I look hard enough, I can figure out which side of a controversial issue is right.  
25) For most important issues, there is one right answer. 
26) I find that my world is relatively stable and consistent.  
27) When two sides disagree, the truth is always somewhere in the middle. 
28) When I am solving a problem, I focus on finding the truth.  
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29) If I think I am right, I am willing to fight to the end  
30) I have a hard time making up my mind about controversial issues. 
31) When two of my friends disagree, I usually have a hard time deciding which of them is 
right.                                             
32) There are always two sides to everything, depending on how you look at it. 
 
9. Using the scale below, select the number that best matches your level of agreement or 
disagreement with each statement. There are no right or wrong answers. 
1-------------2-------------3-------------4-------------5-------------6-------------7  
Strongly disagree    Neither agree nor disagree           Strongly agree       
1) Everything in the universe is somehow related to each other.  
2) Nothing is unrelated.  
3) Everything in the world is intertwined in a causal relationship.   
4) Even a small change in any element of the universe can lead to significant alterations in 
other elements.                                                
5) Any phenomenon entails a numerous number of consequences, although some of them may 
not be known.                                                    
6) It is more desirable to take the middle ground than go to extremes.   
7) When disagreement exists among people, they should search for ways to compromise and 
embrace everyone’s opinions.                               
8) It is more important to find a point of compromise than to debate who is right/wrong, when 
one’s opinions conflict with other’s opinions.               
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9) It is desirable to be in harmony, rather than in discord, with others of different opinions 
than one’s own.                                                   
10) Any phenomenon has numerous numbers of causes, although some of the causes are not 
known.                                           
11) Choosing a middle ground in an argument should be avoided.  
12) We should avoid going to extremes. 
13) Every phenomenon in the world moves in predictable directions.  
14) A person who is currently living a successful life will continue to stay successful. 
15) An individual who is currently honest will stay honest in the future. 
16) If an event is moving toward a certain direction, it will continue to move toward that 
direction.                                          
17) Current situations can change at any time. 
18) Future events are predictable based on present situations. 
19) The whole, rather than its parts, should be considered in order to understand a phenomenon. 
20) It is more important to pay attention to the whole than its parts. 
21) The whole is greater than the sum of its parts. 
22) It is more important to pay attention to the whole context rather than the details. 
23) It is not possible to understand the parts without considering the whole picture. 
24) We should consider the situation a person is faced with, as well as his/her personality in 
order to understand one’s behavior.                     
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Please answer the following questions regarding your daily vitamin supplement usage, your 
fitness condition, and your personal information. 
 
10. Are you currently taking any vitamin supplement? 
| Yes | No | 
 
11. How familiar are you with vitamin supplement? 
Very familiar |  1  |  2  |  3  |  4  |  5  | Not familiar at all  
 
12. How knowledgeable are you about vitamin supplements? 
Very knowledgeable |  1  |  2  |  3  |  4  |  5  | Not knowledgeable at all  
 
13. Please indicate any other health/wellness behavior you do and how you do it in your daily 
life, such as exercise, meditation, health diet, etc. 
______________________________________________________________________ 
 
14. Please indicate your gender. 
A. Female    B.  Male   C. Prefer not to answer 
 
15. How old were you on your last birthday?  ___________________ 
 
16. Please indicate your ethnicity. 
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A. Hispanic or Latino or Mexican / Mexican-American 
B. White / European-American 
C. Black / African-American 
D. Asian / Asian American 
E. American Indian / Alaska Native 
F. Other (Please specify) 
 
17. Have you been living in U.S. for more than 3 years? 
| Yes | No | 
 
18. Which country are you originally from? ________  
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APPENDIX C: PRETEST RESULTS 
 
Occurrence in 30 min Occurrence Usefulness 
  Mean SD Mean SD Mean SD 
Aid metabolism of fats, 
carbohydrates and 
proteins*  
3.95 1.547 5.16 1.348 5.30 1.281 
Aids in the conversion of 
food into energy*  
3.88 1.589 4.84 1.450 5.17 1.242 
Helps with mental 
clarity and focus*  
3.72 1.628 4.75 1.285 4.92 1.395 
Helps support blood 
flow to the brain*  
3.69 1.582 4.63 1.215 4.92 1.384 
Helps support 
neurotransmitters used 
by the body to improve 
healthy brain function*  
3.47 1.553 4.64 1.289 5.08 1.313 
30min-Provide essential 
nutrients that are 
important for proper 
retinal function*  
3.17 1.528 5.36 1.239 5.34 1.263 
Enhance immune 
defense*  
3.16 1.683 5.63 1.189 5.80 1.299 
Protect the body’s cells 
from potential oxidative 
damage 
3.13 1.579 5.05 1.278 5.22 1.351 
Help maintain healthy 
appearance 
3.03 1.699 4.97 1.391 5.27 1.417 
Help to filter harmful 
blue light 
2.94 1.500 3.50 1.563 3.72 1.474 
Table 3 
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Occurrence in 30 min Occurrence Unfavorability 
  Mean SD Mean SD Mean SD 
Unusual or unpleasant 
taste in your mouth* 
4.77 1.942 4.83 1.528 2.83 1.062 
Causing slight 
stomachache due to 
the acidic ingredient* 
4.27 1.556 4.83 1.528 2.80 .929 
Unnatural flush* 4.00 1.737 3.94 1.641 2.52 .976 
Appetite loss* 3.77 1.697 4.09 1.455 2.66 .979 
Headache 3.69 1.859 3.84 1.683 2.09 1.050 
Nausea 3.67 1.791 3.73 1.546 2.03 1.054 
Fast or irregular 
heartbeat 
3.61 1.796 3.72 1.588 1.92 1.013 
Swelling of your face, 
lips, tongue or throat 
3.61 1.814 3.61 1.619 1.84 .979 
Feeling of fever 3.33 1.746 3.19 1.511 1.92 1.013 
Difficulty breathing 3.31 1.661 3.00 1.321 1.67 1.070 
Table 4 
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APPENDIX D: HOLISTIC VS. ANALYTIC THINKING STYLE ANALYSES 
Six outliers that ranged above and below the 1.5 times interquartile (IQR) of people’s 
mean score on Holistic vs. Analytic Thinking Scale were identified and removed, using 
Tukey’s method (Dhana, 2016). After the outliers were removed, the result showed that 
American participants (M = 4.36, SD = .43) were more analytic than Chinese participants (M 
= 4.64, SD = 0.54), twelch (118) = -3.19, p = .002, d = -0.571. (Delacre et al., 2017) (see Figure 
9). I replaced cultural background with people’s holistic vs. analytic thinking style and 
conducted regression analyses to test whether the holistic vs. analytic thinking style by side 
effect information specificity interacted to predict participants’ positive and negative 
expectancies of the supplement’s effects. 
 
Figure 9 
77 
 
A multiple regression was conducted to test if participants’ holistic vs. analytic thinking 
style, together with the side effect information specificity, predicted their positive 
expectancies for the supplement (see Figure 10). There was no main effect of people’s 
holistic vs. analytic thinking style: β = -.001, p = 1.0, meaning that people’s holistic vs. 
analytic thinking style was not significantly related to their positive expectancies of the 
supplement. There was no main effect of side effect information specificity either: β = -1.61, 
p = .28, meaning that people from different specificity groups did not differ in their positive 
expectancies. There was no interaction between holistic vs. analytic thinking style and side 
effect information specificity on positive expectancies: β = .38, p = .25. The two predictors 
were not significantly related to people’s positive expectancies, and they explained 2.1 % of 
the variance of people’s positive expectancies for the supplement (F(3,125) = 0.89, p = .49, 
R2=.021, R2adjusted = -.003).  
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Figure 10 
A multiple regression was conducted to test if participants’ holistic vs. analytic thinking 
style together with the side effect information specificity predicted their negative 
expectancies for the supplement (see Figure 11). There was no main effect of people’s 
holistic vs. analytic thinking style: β = .09, p = .65, meaning that people’s holistic vs. analytic 
thinking style was not significantly related to their negative expectancies of the supplement. 
There was no main effect of side effect information specificity either: β = .05, p = .97, 
meaning that people from different specificity groups did not differ in their negative 
expectancies. There was no interaction between holistic vs. analytic thinking style and side 
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effect information specificity on positive expectancies: β = -.03, p = .92. The two predictors 
were not significantly related to people’s positive expectancies, and they explained 0.5 % of 
the variance of people’s negative expectancies for the supplement (F(3,116) = 0.20, p = .90, 
R2=.005, R2adjusted = -.021). 
 
Figure 11 
 
 
 
